Access to antiviral therapy for chronic hepatitis B during COVID-19

OBJECTIVE: Hepatitis B is an important public health concern. Currently, the COVID-19 pandemic is a major challenge for health systems, and the access to pharmacologic and non-pharmacologic treatment of chronic diseases, such as hepatitis B, may have been affected due to the contingency measures. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertolli¹, Marilia Rocha, Rocha¹, Priscilla Alves, Pinto¹, Vanusa Barbosa, Ono², Suzane Kioko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720759/
https://www.ncbi.nlm.nih.gov/pubmed/36449766
http://dx.doi.org/10.1590/1806-9282.20210300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720759/
https://www.ncbi.nlm.nih.gov/pubmed/36449766
http://dx.doi.org/10.1590/1806-9282.20210300

Ejemplares similares